Aurobindo Pharma (India) Performance
| AUROPHARMA | 1,224 6.70 0.55% |
The firm shows a Beta (market volatility) of 0.26, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Aurobindo Pharma's returns are expected to increase less than the market. However, during the bear market, the loss of holding Aurobindo Pharma is expected to be smaller as well. At this point, Aurobindo Pharma has a negative expected return of -0.37%. Please make sure to confirm Aurobindo Pharma's skewness, as well as the relationship between the day median price and relative strength index , to decide if Aurobindo Pharma performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Aurobindo Pharma Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
Forward Dividend Yield 0.0037 | Payout Ratio 0.0237 | Last Split Factor 2:1 | Forward Dividend Rate 4.5 | Ex Dividend Date 2024-02-20 |
1 | UBS starts Aurobindo Pharma stock with sell, sees low growth - Investing.com | 09/26/2024 |
2 | Aurobindo Pharma Ltd drops for fifth straight session - Business Standard | 11/11/2024 |
| Begin Period Cash Flow | 43.9 B |
Aurobindo |
Aurobindo Pharma Relative Risk vs. Return Landscape
If you would invest 154,560 in Aurobindo Pharma Limited on August 27, 2024 and sell it today you would lose (32,190) from holding Aurobindo Pharma Limited or give up 20.83% of portfolio value over 90 days. Aurobindo Pharma Limited is generating negative expected returns and assumes 1.2243% volatility on return distribution over the 90 days horizon. Simply put, 10% of stocks are less volatile than Aurobindo, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Aurobindo Pharma Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Aurobindo Pharma's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Aurobindo Pharma Limited, and traders can use it to determine the average amount a Aurobindo Pharma's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.301
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | AUROPHARMA |
Estimated Market Risk
| 1.22 actual daily | 10 90% of assets are more volatile |
Expected Return
| -0.37 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.3 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Aurobindo Pharma is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Aurobindo Pharma by adding Aurobindo Pharma to a well-diversified portfolio.
Aurobindo Pharma Fundamentals Growth
Aurobindo Stock prices reflect investors' perceptions of the future prospects and financial health of Aurobindo Pharma, and Aurobindo Pharma fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Aurobindo Stock performance.
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0677 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 719.77 B | ||||
| Shares Outstanding | 580.8 M | ||||
| Price To Book | 2.30 X | ||||
| Price To Sales | 2.34 X | ||||
| Revenue | 290.02 B | ||||
| Gross Profit | 135.62 B | ||||
| EBITDA | 61.79 B | ||||
| Net Income | 31.73 B | ||||
| Cash And Equivalents | 27.3 B | ||||
| Total Debt | 66.48 B | ||||
| Book Value Per Share | 528.88 X | ||||
| Cash Flow From Operations | 24.65 B | ||||
| Earnings Per Share | 61.31 X | ||||
| Total Asset | 450.72 B | ||||
| Retained Earnings | 268.01 B | ||||
About Aurobindo Pharma Performance
By analyzing Aurobindo Pharma's fundamental ratios, stakeholders can gain valuable insights into Aurobindo Pharma's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Aurobindo Pharma has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Aurobindo Pharma has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Aurobindo Pharma is entity of India. It is traded as Stock on NSE exchange.Things to note about Aurobindo Pharma performance evaluation
Checking the ongoing alerts about Aurobindo Pharma for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Aurobindo Pharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Aurobindo Pharma generated a negative expected return over the last 90 days | |
| Aurobindo Pharma is unlikely to experience financial distress in the next 2 years | |
| About 52.0% of the company shares are held by company insiders | |
| Latest headline from news.google.com: Aurobindo Pharma Ltd drops for fifth straight session - Business Standard |
- Analyzing Aurobindo Pharma's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Aurobindo Pharma's stock is overvalued or undervalued compared to its peers.
- Examining Aurobindo Pharma's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Aurobindo Pharma's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Aurobindo Pharma's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Aurobindo Pharma's stock. These opinions can provide insight into Aurobindo Pharma's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Aurobindo Stock analysis
When running Aurobindo Pharma's price analysis, check to measure Aurobindo Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aurobindo Pharma is operating at the current time. Most of Aurobindo Pharma's value examination focuses on studying past and present price action to predict the probability of Aurobindo Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aurobindo Pharma's price. Additionally, you may evaluate how the addition of Aurobindo Pharma to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |